VANCOUVER, British Columbia & MUMBAI, India–(BUSINESS WIRE)–Canadian pharmaceutical company SaNOtize Research & Development Corp., (SaNOtize), and Glenmark Pharmaceuticals Limited (Glenmark), a global, innovation-driven pharmaceutical company, today announced successful results of Phase 3 clinical trials and approval from India’s drug regulator for the treatment of adult patients with COVID-19 who have a risk of progression of the disease.
Read more here.
![[Arbe Robotics in Wards Auto] How Autonomous Vehicles Navigate the Winter](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
